Arca Biopharma | ABIO - Current Liabilities


Arca Biopharma reported $16.63M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Alterity Therapeutics Limited AUD 1.73M 2.77M Dec/2025
Amgen USD 24.96B 534M Mar/2026
Arca Biopharma USD 16.63M 1.26M Mar/2026
Biogen USD 3B 350.5M Mar/2026
Brainstorm Cell Therapeutics USD 11.76M 757K Mar/2026
Bristol-Myers Squibb USD 19.16B 4.26B Mar/2026
Capricor Therapeutics USD 33.64M 2.2M Mar/2026
Cipla INR 70.14B 7.16B Mar/2026
Clal Biotechnology ILS 6.66M 3.75M Dec/2023
Compugen USD 22.04M 533K Mar/2026
CSL USD 4.61B 207M Dec/2025
Cytokinetics USD 199.18M 3.27M Mar/2026
Daiichi Sankyo JPY 778.55B 77.51B Dec/2025
Gilead Sciences USD 9.48B 2.34B Mar/2026
GlaxoSmithKline GBP 22.43B 1.04B Mar/2026
Grifols EUR 2.37B 156.97M Dec/2025
Laboratory Of America USD 2.64B 182.5M Mar/2026
Myriad Genetics USD 130.2M 3.6M Mar/2026
Otsuka Holdings JPY 686.12B 63B Mar/2026
Pfizer USD 34.35B 2.64B Mar/2026
United Therapeutics USD 599.1M 38.5M Mar/2026